"Parkinson-dementia" diseases: A comparison by double tracer SPECT studies

Parkinsonism and Related Disorders

Volumn 15, Issue 10, 2009, Pages 762-766

  Rossi, Carlo ^a   Volterrani, Duccio ^a   Nicoletti, Valentina ^a   Manca, Gianpiero ^a   Frosini, Daniela ^a   Kiferle, Lorenzo ^a   Unti, Elisa ^a   De Feo, Paola ^a   Bonuccelli, Ubaldo ^a   Ceravolo, Roberto ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Dementia with Lewy bodies; Parkinson disease; SPECT

Indexed keywords

CYSTEINE ETHYL ESTER TC 99M; LEVODOPA; TRACER;

AGED; ARTICLE; BRAIN PERFUSION; DIAGNOSTIC IMAGING; DIFFUSE LEWY BODY DISEASE; FEMALE; FRONTAL LOBE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; NIGRONEOSTRIATAL SYSTEM; OCCIPITAL LOBE; PARIETAL LOBE; PARKINSON DISEASE; PRESYNAPTIC NERVE; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; UNIFIED PARKINSON DISEASE RATING SCALE;

AGED; AGED, 80 AND OVER; BRAIN MAPPING; CEREBROVASCULAR CIRCULATION; CORPUS STRIATUM; DEMENTIA; DITERPENES, CLERODANE; FEMALE; HUMANS; IODINE RADIOISOTOPES; LEWY BODY DISEASE; MALE; PARKINSON DISEASE; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TROPANES;

EID: 70450222738     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2009.05.012     Document Type: Article

References (30)

1. Aarsland D., Andersen K., Larsen J.P., Lolk A., and Kragh-Sørensen P. Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Arch Neurol 60 (2003) 387-392
2. Hobson P., and Meara J. Risk and incidence of dementia in a cohort of older subjects with Parkinson's disease in the United Kingdom. Mov Disord 19 (2004) 1043-1049
3. McKeith I.G., Dickson D.W., Lowe J., Emre M., O'Brien J.T., Feldman H., et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 65 (2005) 1863-1872
4. Noe E., Marder K., Bell K.L., Jacobs D.M., Manly J.J., and Stern Y. Comparison of dementia with Lewy bodies to Alzheimer's disease and Parkinson's disease with dementia. Mov Disord 19 (2004) 60-67
5. Aarsland D., Litvan I., Salmon D., Galasko D., Wentzel-Larsen T., and Larsen J.P. Performance on the dementia rating scale in Parkinson's disease with dementia and dementia with Lewy bodies: comparison with progressive supranuclear pasly and Alzheimer's disease. J Neurol Neurosurg Psychiatry 74 (2003) 1215-1220
6. Gnanalingham K.K., Byrne E.J., Thornton A., Sambrook M.A., and Bannister P. Motor and cognitive function in Lewy body dementia: comparison with Alzheimer's and Parkinson's disease. J Neurol Neurosurg Psychiatry 62 (1997) 243-252
7. Molloy S., McKeith I.G., O'Brien J.T., and Burn D.J. The role of levodopa in the management of dementia with Lewy bodies. J Neurol Neurosurg Psychiatry 76 (2005) 1200-1203
8. Ballard C., Ziabreva I., Perry R., Larsen J.P., O'Brien J., McKeith I., et al. Differences in neuropathologic characteristics across the Lewy body dementia spectrum. Neurology 67 (2006) 1931-1934
9. Burton E.J., McKeith I.G., Burn D.J., Williams E.D., and O'Brien J.T. Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls. Brain 127 (2004) 791-800
10. Beyer M.K., Larsen J.P., and Aarsland D. Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodies. Neurology 69 (2007) 747-754
11. O'Brien J.T., Colloby S., Fenwick J., Williams E.D., Firbank M., Burn D., et al. Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies. Arch Neurol 61 (2004) 919-925
12. Walker Z., Costa D.C., Walker R.W., Lee L., Livingston G., Jaros E., et al. Striatal dopamine transporter in dementia with Lewy bodies and Parkinson disease: a comparison. Neurology 62 (2004) 1568-1572
13. Vander Borght T., Minoshima S., Giordani B., Foster N.L., Frey K.A., Berent S., et al. Cerebral metabolic differences in Parkinson's and Alzheimer's diseases matched for dementia severity. J Nucl Med 35 (1997) 797-802
14. Ishii K., Imamura T., Sasaki M., Yamaji S., Sakamoto S., Kitagaki H., et al. Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer's disease. Neurology 51 (1998) 125-130
15. Yong S.W., Yoon J.K., An Y.S., and Lee P.H. A comparison of cerebral glucose metabolism in Parkinson's disease, Parkinson's disease dementia and dementia with Lewy bodies. Eur J Neurol 14 (2007) 1357-1362
16. Lobotesis K., Fenwick J.D., Phipps A., Ryman A., Swann A., Ballard C., et al. Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD. Neurology 56 (2001) 643-649
17. Schillaci O., Pierantozzi M., Filippi L., Manni C., Brusa L., Danieli R., et al. The effect of levodopa therapy on dopamina transporter SPECT imaging with [123I]FP-CIT in patients with Parkinson's disease. Eur J Nucl Med Mol Imaging 32 (2005) 1452-1456
18. Ito K., Morrish P.K., Rakshi J.S., Uema T., Ashburner J., Bailey D.L., et al. Statistical parametric mapping with 18F-dopa PET shows bilaterally reduced striatal and nigral dopaminergic function in early Parkinson's disease. J Neurol Neurosurg Psychiatry 66 (1999) 754-758
19. Tsuboi Y., and Dickson D.W. Dementia with Lewy bodies and Parkinson's disease with dementia: are they different?. Parkinsonism Related Disord 11 Suppl. 1 (2005) S47-S51
20. Gomperts S.N., Rentz D.M., Moran E., Becker J.A., Locascio J.J., Klunk W.E., et al. Imaging amyloyd deposition in Lewy body diseases. Neurology 71 (2008) 903-910
21. Abe Y., Kachi T., Kato T., Arahata Y., Yamada T., Washimi Y., et al. Occipital hypoperfusion in Parkinson's disease without dementia: correlation to impaired cortical visual processing. J Neurol Neurosurg Psychiatry 74 (2003) 419-422
22. Harding A.J., Broe G.A., and Halliday G.M. Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe. Brain 125 (2002) 391-403
23. Nagano-Saito A., Washimi Y., Arahata Y., Iwai K., Kawatsu S., Ito K., et al. Visual hallucination in Parkinson's disease with FDG PET. Mov Disord 19 (2004) 801-806
24. Stebbins G.T., Goetz C.G., Carrillo M.C., Bangen K.J., Turner D.A., Glover G.H., et al. Altered cortical visual processing in PD with hallucinations: an fMRI study. Neurology 63 (2004) 1409-1416
25. Bohnen N.I., Minoshima S., Giordani B., Frey K.A., and Kuhl D.E. Motor correlates of occipital glucose hypometabolism in Parkinson's disease without dementia. Neurology 52 (1999) 541-546
26. O'Brien J.T., Colloby S.J., Pakrasi S., Perry E.K., Pimlott S.L., Wyper D.J., et al. Nicotinic alpha4beta2 receptor binding in dementia with Lewy bodies using 123 -5IA-85380 SPECT demonstrates a link between occipital changes and visual hallucinations. Neuroimage 40 (2008) 1056-1063
27. Rinne J.O., Rummukainen J., Paljärvi L., Rinne U.K., et al. Dementia in Parkinson's disease is related to neuronal loss in the medial substantia nigra. Ann Neurol 26 (1989) 47-50
28. Jokinen P., Brück A., Aalto S., Forsback S., Parkkola R., Rinne J.O., et al. Impaired cognitive performance in Parkinson's disease is related to caudate dopaminergic hypofunction and hippocampal atrophy. Parkinsonism Relat Disord 15 (2009) 88-93
29. Costa A., Peppe A., Brusa L., Caltagirone C., Gatto I., Carlesimo G.A., et al. Levodopa improves time-based prospective memory in Parkinson's disease. J Int Neuropsychol Soc 14 (2008) 601-610
30. Press D.Z., Mechanic D.J., Tarsy D., and Manoach D.S. Cognitive slowing in Parkinson's disease resolves after practice. J Neurol Neurosurg Psychiatry 73 (2002) 524-528